Why this status
- 14 Apr 2020: Trial registered, NCT04344730
The trials
NCT04344730: Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia
- State
- State not given
- Phase
- No phase
- People
- 550 taking part
- Started
- 10 Apr 2020
- Primary completion
- 31 Dec 2021
- Arms
- Standard oxygen 2, mechanically ventilated 2
- Results
- None posted
- 10 Apr 2020: Trial started
- 14 Apr 2020: Trial registered
How the status changed
- 19 Nov 2026: First set: Trial registered
About the treatment
Kind of treatment: Drug.
Also known as Aeroseb-dex, Ciprodex component dexamethasone, Decaderm, Decadron, Decaspray, Dexa-sine, Dexacidin component dexamethasone, Dexacortal, Dexacortin, Dexamonozon, Dexapos, Dexasite, Dexasone, Dexasporin component dexamethasone, Dexone, Dextenza, Dexycu, Dexamethasone injection, Fortecortin, Hemady, Hexadrol, Isopto-dex, Loverine, Luxazone, Maxidex, Maxitrol component dexamethasone, Ozurdex, Tobradex component dexamethasone, Tobradex st component dexamethasone.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.